Zentalis Pharmaceuticals Share Price (NASDAQ: ZNTL)
$1.7
Last updated on
Check the interactive Zentalis Pharmaceuticals Stock chart to analyse performance
Zentalis Pharmaceuticals stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.69Today's High:$1.78
0.88%
Downside
Day's Volatility :5.34%
Upside
4.49%
- 52 Weeks Low:$1.0152 Weeks High:$5.44
40.59%
Downside
52 Weeks Volatility :81.43%
Upside
68.75%
Zentalis Pharmaceuticals Stock Returns
Zentalis Pharmaceuticals Inc Key Stats
Check Zentalis Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Zentalis Pharmaceuticals Stock including INR - Dollar returns
The Zentalis Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Zentalis Pharmaceuticals investment value today
Current value as on today
₹57,916
Returns
Returns from Zentalis Pharmaceuticals Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Zentalis Pharmaceuticals Stock
Global Institutional Holdings in Zentalis Pharmaceuticals Inc
Name
Holdings %
Matrix Capital Management Company, LLC
19.35%
BlackRock Inc
5.86%
Millennium Management LLC
4.26%
Vanguard Group Inc
4.00%
Acadian Asset Management LLC
3.71%
Opaleye Management Inc
2.67%
Analyst Recommendation on Zentalis Pharmaceuticals Stock
Buy
82%Buy
17%Hold
0%Sell
Based on 17 Wall street analysts offering stock ratings for Zentalis Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Zentalis Pharmaceuticals Share Price Target
What analysts predicted
Upside of 263.97%
Target:
$6.19
Current:
$1.70
Zentalis Pharmaceuticals share price target is $6.19, a slight Upside of 263.97% compared to current price of $1.70 as per analysts' prediction.
Zentalis Pharmaceuticals Stock Insights
Price Movement
In the last 7 days, ZNTL stock has moved down by -14.8%ZNTL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 121.1%ZNTL vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 206.0%Price to Sales
ForZNTL every $1 of sales, investors are willing to pay $4.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Zentalis Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Zentalis Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.
Zentalis Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 26.49% | -11.72% | -47.52% | -93.92% | -94.68% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.96 | -0.5 | -0.25 | NA | 3.81 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $131.3M | -94.68% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Zentalis Pharmaceuticals Inc
Key Management of Zentalis Pharmaceuticals Inc
Important FAQs about investing in ZNTL Stock from India :
What is Zentalis Pharmaceuticals share price today?
Zentalis Pharmaceuticals share price today is $1.70 as on at the close of the market. Zentalis Pharmaceuticals share today touched a day high of $1.78 and a low of $1.69.
What is the 52 week high and 52 week low for Zentalis Pharmaceuticals share?
Zentalis Pharmaceuticals share touched a 52 week high of $5.44 and a 52 week low of $1.01. Zentalis Pharmaceuticals stock price today i.e. is closed at $1.70, lower by 68.75% versus the 52 week high.
How to invest in Zentalis Pharmaceuticals Stock (ZNTL) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Zentalis Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zentalis Pharmaceuticals Shares that will get you 0.8824 shares as per Zentalis Pharmaceuticals share price of $1.70 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Zentalis Pharmaceuticals Stock (ZNTL) from India?
Indian investors can start investing in Zentalis Pharmaceuticals (ZNTL) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Zentalis Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Zentalis Pharmaceuticals share’s latest price of $1.70 as on August 30, 2025 at 1:29 am IST, you will get 5.8824 shares of Zentalis Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Zentalis Pharmaceuticals has given to Indian investors in the last 5 years?
Zentalis Pharmaceuticals stock has given -94.68% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%